These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8196061)

  • 1. Two crystal forms of the extracellular domain of type I tumor necrosis factor receptor.
    Rodseth LE; Brandhuber B; Devine TQ; Eck MJ; Hale K; Naismith JH; Sprang SR
    J Mol Biol; 1994 Jun; 239(2):332-5. PubMed ID: 8196061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor receptor superfamily.
    Naismith JH; Sprang SR
    J Inflamm; 1995-1996; 47(1-2):1-7. PubMed ID: 8913924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.
    Gordon NC; Pan B; Hymowitz SG; Yin J; Kelley RF; Cochran AG; Yan M; Dixit VM; Fairbrother WJ; Starovasnik MA
    Biochemistry; 2003 May; 42(20):5977-83. PubMed ID: 12755599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.
    Scallon BJ; Trinh H; Nedelman M; Brennan FM; Feldmann M; Ghrayeb J
    Cytokine; 1995 Nov; 7(8):759-70. PubMed ID: 8664442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF alpha and the TNF receptor superfamily: structure-function relationship(s).
    Idriss HT; Naismith JH
    Microsc Res Tech; 2000 Aug; 50(3):184-95. PubMed ID: 10891884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble and cell surface receptors for tumor necrosis factor.
    Wallach D; Engelmann H; Nophar Y; Aderka D; Kemper O; Hornik V; Holtmann H; Brakebusch C
    Agents Actions Suppl; 1991; 35():51-7. PubMed ID: 1664189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes.
    Karpusas M; Cachero TG; Qian F; Boriack-Sjodin A; Mullen C; Strauch K; Hsu YM; Kalled SL
    J Mol Biol; 2002 Feb; 315(5):1145-54. PubMed ID: 11827482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of tumor necrosis factor binding protein disulfide structure: deviation of the fourth domain structure from the TNFR/NGFR family cysteine-rich region signature.
    Jones MD; Hunt J; Liu JL; Patterson SD; Kohno T; Lu HS
    Biochemistry; 1997 Dec; 36(48):14914-23. PubMed ID: 9398215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of the extracellular domain of the type I tumor necrosis factor receptor.
    Naismith JH; Devine TQ; Kohno T; Sprang SR
    Structure; 1996 Nov; 4(11):1251-62. PubMed ID: 8939750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization and preliminary crystallographic analysis of a TNF-beta-55 kDa TNF receptor complex.
    D'Arcy A; Banner DW; Janes W; Winkler FK; Loetscher H; Schönfeld HJ; Zulauf M; Gentz R; Lesslauer W
    J Mol Biol; 1993 Jan; 229(2):555-7. PubMed ID: 8381494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of RANK ligand involved in bone metabolism.
    Ito S; Hata T
    Vitam Horm; 2004; 67():19-33. PubMed ID: 15110169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation.
    Kim HM; Yu KS; Lee ME; Shin DR; Kim YS; Paik SG; Yoo OJ; Lee H; Lee JO
    Nat Struct Biol; 2003 May; 10(5):342-8. PubMed ID: 12715002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TNF-TNF receptor system.
    Hehlgans T; Männel DN
    Biol Chem; 2002 Oct; 383(10):1581-5. PubMed ID: 12452434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for self-association and receptor recognition of human TRAF2.
    Park YC; Burkitt V; Villa AR; Tong L; Wu H
    Nature; 1999 Apr; 398(6727):533-8. PubMed ID: 10206649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-receptor binding revealed by the TNF family member TALL-1.
    Liu Y; Hong X; Kappler J; Jiang L; Zhang R; Xu L; Pan CH; Martin WE; Murphy RC; Shu HB; Dai S; Zhang G
    Nature; 2003 May; 423(6935):49-56. PubMed ID: 12721620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.
    Mongkolsapaya J; Grimes JM; Chen N; Xu XN; Stuart DI; Jones EY; Screaton GR
    Nat Struct Biol; 1999 Nov; 6(11):1048-53. PubMed ID: 10542098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TNF ligand superfamily and its relevance for human diseases.
    Gruss HJ; Dower SK
    Cytokines Mol Ther; 1995 Jun; 1(2):75-105. PubMed ID: 9384666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
    Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
    Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of an efficient small molecular weight tumour necrosis factor/lymphotoxin antagonist.
    Neve R; Kissonerghis M; Clark J; Feldmann M; Chernajovsky Y
    Cytokine; 1996 May; 8(5):365-70. PubMed ID: 8726664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.